Large quantities of biological samples collected in clinical trials are lost, switched, or unusable due to handling errors. This webinar explores the impact across study design, conduct, data analysis, reporting, and regulatory approval.
Topics include:
The prevalence of errors and impact of unusable samples (i.e., lost, improper handling or labeling)
The importance of ethical considerations of the patients in the study design and sampling schema
Downstream implications for the bioanalytical labs
Regulatory impact of sample mishandling and loss
